Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 Biomarker BEFREE We suggest that the carcinogenesis of EBV-associated gastric cancers may be closely associated with a p16 abnormality. 16619489

2006

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 PosttranslationalModification BEFREE We aimed to evaluate the inactivation of COX-2, HMLH1 and CDKN2A by promoter methylation and its relationship with the infection by different Helicobacter pylori strains in gastric cancer. 21849808

2011

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 Biomarker BEFREE Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer. 20637757

2010

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 Biomarker BEFREE To investigate the expression of human telomerase reverse transcriptase gene (hTRT) in gastric cancer (GC) and its relevance with cell cycle regulators including P16INK4, cyclin and P53. 12632490

2003

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 GeneticVariation BEFREE To explore germline hypermethylation of the tumor suppressor genes MLH1, CDH1 and P16(INK4a) in suspected cases of hereditary gastric cancer (GC). 22228973

2012

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 Biomarker BEFREE These results suggest that p16(INK4a) promoter hypermethylation is an early and frequent event in gastric carcinogenesis and may serve as a new prognostic biomarker for the risk of gastric cancers. 11477571

2001

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 AlteredExpression BEFREE Therefore, alteration and heterozygous expression of CDKN2 appears to be involved in the pathogenesis of human gastric cancers. 9139866

1997

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 PosttranslationalModification BEFREE The results suggest that hypermethylation and abnormality of p16 gene may play a key role in the progress of gastric cancer. 12632489

2003

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 PosttranslationalModification BEFREE The relationship between P16 gene promoter methylation and gastric cancer: a meta-analysis based on Chinese patients. 25693938

2014

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 Biomarker BEFREE The present study demonstrated for the first time that gastric cancer patients with p16INK4a methylation specifically benefit from 5-FU-based adjuvant chemotherapy. 18008030

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 AlteredExpression BEFREE The overexpression of p16 seems to be a common event in the development of both intestinal and diffuse type of gastric cancer and it is likely that it may be driven by features of the neoplastic state. 12145426

2002

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 PosttranslationalModification BEFREE The objective of this study was to investigate the contribution of p16 inactivation in gastric cancer and to compare it with p53. 12469165

2003

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 GeneticVariation BEFREE The methylation level of the p16 gene was also associated with the presence of intestinal-type gastric cancer (p = 0.017). 17438355

2007

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 GeneticVariation BEFREE The frequencies of LOH in two microsatellite sites, D9s171 and D9s1604, in p16 genome were associated with development of gastric cancer and no significant correlation was demonstrated between the LOH frequency and the cell differentiated types of tumor cells or clinical stages. 12632492

2003

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 AlteredExpression BEFREE The Aζ value of the receiver-operator characteristic curve for methylated p16 was 0.899 for serum and PPWs, compared to that in GC tissues. 24817951

2014

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 AlteredExpression BEFREE Targeted inactivation of HDAC2 restores p16INK4a activity and exerts antitumor effects on human gastric cancer. 23175521

2013

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 AlteredExpression BEFREE Relative expression of SNHG7 is upregulated in gastric cancer tissues and cells, and partially contributes to the development and progression of gastric cancer through regulation of p15 and p16 expressions. 29131253

2017

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 PosttranslationalModification BEFREE p16(INK4a) and p14(ARF) genes are frequently inactivated by homozygous deletion and methylation of the 5'CpG islands in gastric cancer, which may play an important role in the carcinogenesis of gastric cancer. 12890389

2003

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 GeneticVariation BEFREE Overall, 78% of GC cases harbored one clinically relevant GA or more, with the most frequent alterations being found in TP53 (50%), ARID1A (24%), KRAS (16%), CDH1 (15%), CDKN2A (14%), CCND1 (9.5%), ERBB2 (8.5%), PIK3CA (8.6%), MLL2 (6.9%), FGFR2 (6.0%), and MET (6.0%). 25882375

2015

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 AlteredExpression BEFREE Our results demonstrate that STAT3, but not STAT5, is involved in GC cell growth and cell cycle progression through regulation of gene expression, such as Bcl-2, p16(ink4a) and p21(waf1/cip1). 22328012

2012

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 Biomarker BEFREE On the other hand, the observed pattern of p16 (INK4A) hypermethylation suggests that this event is a good marker for the gastric cancer pathway in the Pará state population. 23504555

2013

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 Biomarker BEFREE No precursor lesions were available from the gastric cancers that had loss of both MTAP and p16. 16224217

2005

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 PosttranslationalModification BEFREE Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer. 18622497

2008

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 PosttranslationalModification BEFREE Methylation of the p16 gene is frequently detected in lymphatic-invasive gastric cancer. 20683001

2010

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.400 PosttranslationalModification BEFREE Low serum IL-6 levels were associated with p16 or DAPK gene methylation in patients with gastric cancer. 17139167

2006